Methotrexate Concentration for Injection
The standard concentration of methotrexate solution for injection is 25 mg/ml. 1
Dosing for Ectopic Pregnancy
- The standard dosing regimen for ectopic pregnancy is a single intramuscular injection of methotrexate at 50 mg/m² of body surface area 2, 1
- This dose may be repeated as needed based on β-hCG level monitoring 1, 3
- For high-risk cases, more intensive regimens may be required 1
- The solution is typically administered as a single intramuscular injection, though some protocols use multiple doses 2, 3
Administration Considerations
- Pre-treatment laboratory testing is required, including:
- Methotrexate is contraindicated in patients with:
Efficacy and Treatment Outcomes
- Success rates for methotrexate treatment of ectopic pregnancy range from 71-95% 3, 4
- Treatment failure is associated with:
Important Monitoring and Follow-up
- Serial β-hCG monitoring is essential until levels are undetectable 1, 3
- Patients should be monitored for potential rupture, which can occur up to 32 days after treatment 3, 4
- Common side effects include nausea/vomiting (30%), gastritis, stomatitis (7%), and reversible alopecia (3%) 1
Alternative Dosing Approaches
- Some studies have investigated lower doses (22-40 mg/m²) with similar success rates to the standard 50 mg/m² dose 5
- Local injection directly into the ectopic sac (1 mg/kg) has shown higher success rates (91.5%) compared to intramuscular injection (71.4%), particularly when β-hCG levels are ≥2000 mIU/mL 6
- Alternative dosing of 75 mg intramuscular (not based on body surface area) has shown 94.9% effectiveness in medical abortion studies 7
Warning Signs Requiring Immediate Attention
- Severe abdominal pain, signs of hemodynamic instability, heavy vaginal bleeding, and shoulder pain require immediate medical attention 1, 4
- Ruptured ectopic pregnancy must be considered in the differential diagnosis of patients who present with concerning symptoms after methotrexate therapy 2
Remember that methotrexate is administered in its concentrated form (25 mg/ml) and dosed according to body surface area calculations for most indications.